serine protease inhibitor, Kunitz type 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| neural tube closure | ||
| neural tube closure | ||
| establishment or maintenance of cell polarity | ||
| negative regulation of peptidase activity |
|
|
| negative regulation of cell-cell adhesion |
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytoplasm | ||
| Golgi apparatus | ||
| plasma membrane | ||
| membrane |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| serine-type endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026